"/> Invitrogen™ Peptide synthétique PRR5 humain | B-LABO France

Invitrogen™ Peptide synthétique PRR5 humain

Réf. : BL-RE-176328Réf. fabricant : 15295239 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
55615
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
P85299
Nom usuel
Human PRR5
Marque
Invitrogen

PRR5 Synthetic Peptide, PEP-1242, from Invitrogen.

MARK1 (MAP/microtubule affinity-regulating kinase 1) belongs to the MARK family of serine/threonine kinases. MARK family protein kinases phosphorylate microtubule-associated proteins and may play a role in cytoskeletal stability. MARK2 refers to MAP/microtubule affinity-regulating kinase 2 isoform a [Homo sapiens]. EMK (ELKL Motif Kinase) is a small family of ser/thr protein kinases involved in the control of cell polarity, microtubule stability and cancer. Several cDNA clones have been isolated that encoded two isoforms of the human ser/thr protein kinase EMK1 called MARK2. MARK3 was originally identified as a marker that was induced by treatment with DNA damaging agents, and loss of MARK3 was found with carcinogenesis in the pancreas. MARK4 contains an N terminal serine/threonine kinase domain, a central ubiquitin associated domain, and a C terminal KA1 associated kinase domain. RT PCR analysis detects upregulated expression of the gene for MARK4 in nearly all clinical hepatocellular carcinoma cells.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176328
Réf. fabricant15295239
Gene ID (Entrez)55615
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionP85299
Nom usuelHuman PRR5
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)PRR5
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.